David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 43,159 shares at $1.67 ($73K) on 2018-11-09, disclosed to the SEC on 2018-11-13.
Scheduled sale ($73k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.67 | 783 | $1K | 1.8% |
| 2 | $1.67 | 1,696 | $3K | 3.9% |
| 3 | $1.67 | 23,617 | $39K | 54.3% |
| 4 | $1.70 | 512 | $870 | 1.2% |
| 5 | $1.70 | 1,109 | $2K | 2.6% |
| 6 | $1.70 | 15,442 |
| $26K |
| 36.2% |
| Total | $1.68 avg | 43,159 | $73K | 100% |
| Filing → |
| GEN | SELL | 2018-11-15 | $53K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |
| GEN | SELL | 2018-11-07 | $18K | — | Filing → |